Article info

Original research
Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials

Authors

  1. Correspondence to Professor Ruth H Keogh, Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK; ruth.keogh{at}lshtm.ac.uk
View Full Text

Citation

Keogh RH, Cosgriff R, Andrinopoulou E, et al
Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials

Publication history

  • Received September 28, 2020
  • Accepted August 12, 2021
  • First published September 23, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.